954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent adenovirus

Bibliographic Details
Published in:Journal for ImmunoTherapy of Cancer
Main Authors: Brachtlova, Tereza, Abramovitch, Allan, Giddens, Jonathan, Incze, Peter, Jansz, Kenneth, Casey, Richard, Beusechem, Victor van, Dong, Wenliang
Format: Conference Object
Language:unknown
Published: BMJ Publishing Group Ltd 2021
Subjects:
Online Access:http://dx.doi.org/10.1136/jitc-2021-sitc2021.954
https://syndication.highwire.org/content/doi/10.1136/jitc-2021-SITC2021.954
Description
Description not available.